CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- 4 Grant or award Director acquired 923,374 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 238,333 shares (grant or award)
- 4 Open-market sale Director sold 100,000 shares at $0.46 ($45,540)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 200,000 shares (grant or award)
- 4 Open-market buy Member of 10% owner group bought 100,000 shares at $0.28 ($28,000)
- 4 Open-market buy Member of 10% owner group bought 200,000 shares at an average $0.29 ($57,380)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 33,023 shares at $0.28 ($9,246)
- 4 Open-market sale Director sold 71,650 shares at an average $0.30 ($21,507)
- 4/A Insider Changes in Ownership
- 4 Exercise or conversion 10% owner acquired 14,624,999 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 17 · 329 filings